Chemical Structure (Lot00 0006 01)
Lotronex
Product Images NDC 65483-894
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lotronex (NDC 65483-894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prometheus Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lot00 0006 02)
Principal Display Panel (Lotronex 0.5 mg Bottle Label)
LOTRONEX is a medication that contains alosetron hydrochloride in film-coated tablets, which require dispensing with a medication guide attached due to federal law. It should be stored in a light-resistant container at controlled room temperature. For more information on dosage and administration, see the prescribing information in the USP. The medication is manufactured by Prometheus Laboratories Inc. in Canada.*
Principal Display Panel (Lotronex 0.5 mg Carton)
Each film-coated tablet of NDX 03 EIRENES LUTITTNEX (also known as LOTRONEX) contains 0.5 mg alosetron hydrochloride. The medication guide is included in the box, which must be followed for dispensing it as per federal law. A pharmacist's label must be affixed to the package.*
Principal Display Panel (Lotronex 1 mg Bottle Label)
LOTRONEX (alosetron hydrochloride) is a medication available in tablet form, with each film-coated tablet containing 1 mg of alosetron hydrochloride. Dispensing LOTRONEX requires the Medication Guide attached in accordance with Federal Law. The medication should be maintained in a tight, light-resistant container, and dosage and administration details are available in the prescribing information in the USP. The recommended storage temperature is 20-25°C (68-77°F). This medication is manufactured by Prometheus Laboratories Inc. in San Diego, CA and made in Canada.*
Principal Display Panel (Lotronex 1 mg Carton)
LOTRONEX is a medication that comes in the form of film-coated tablets. Each tablet contains 1 mg of alosetron hydrochloride. The medication guide is included in the box and dispensing is required under federal law.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
